Andere Kunden interessierten sich auch für
![Valutazione immunoistochimica di VEGF-C e COX-2 nel CPT]( "Valutazione immunoistochimica di VEGF-C e COX-2 nel CPT")
Valutazione immunoistochimica di VEGF-C e COX-2 nel CPT26,99 €![Évaluation immunohistochimique du VEGF-C et de la COX-2 dans le CPT]( "Évaluation immunohistochimique du VEGF-C et de la COX-2 dans le CPT")
Évaluation immunohistochimique du VEGF-C et de la COX-2 dans le CPT26,99 €![Ocena immunohistochemiczna VEGF-C i COX-2 w CPT]( "Ocena immunohistochemiczna VEGF-C i COX-2 w CPT")
Ocena immunohistochemiczna VEGF-C i COX-2 w CPT26,99 €![Immunhistochemische Bewertung von VEGF-C und COX-2 bei CPT]( "Immunhistochemische Bewertung von VEGF-C und COX-2 bei CPT")
Immunhistochemische Bewertung von VEGF-C und COX-2 bei CPT39,90 €![Avaliação imuno-histoquímica de VEGF-C e COX-e em CPT]( "Avaliação imuno-histoquímica de VEGF-C e COX-e em CPT")
Avaliação imuno-histoquímica de VEGF-C e COX-e em CPT23,99 €![Immunohistochemical and Genetic Study of Breast Cancer in Iraqi Women]( "Immunohistochemical and Genetic Study of Breast Cancer in Iraqi Women")
Immunohistochemical and Genetic Study of Breast Cancer in Iraqi Women28,99 €![Ovarian Cancer: Molecular and Immunological Study of Angiogenesis]( "Ovarian Cancer: Molecular and Immunological Study of Angiogenesis")
Ovarian Cancer: Molecular and Immunological Study of Angiogenesis34,99 €
Thyroid cancer is the most common malignant neoplasm of the endocrine system. Although it is a relatively rare pathology, accounting for approximately 1% of new cases of malignant diseases, a trend toward increased incidence has been recognized in various parts of the world. This study analyzed the expression of COX-2 and VEGF-C in patients diagnosed with papillary thyroid carcinoma (PTC) in Goiânia, as well as the possible associations between the expression of these markers and the following factors: lymph node metastasis, distant metastasis, tumor size, age, extravasation/invasion of adjacent tissues, and gender. A total of 165 patients with a confirmed histopathological diagnosis of PTC were evaluated. The results of this study corroborate other studies that have demonstrated the usefulness of COX-2 and VEGF-C proteins in identifying PTC patients at higher risk of disease progression due to their association with the presence of regional lymph node metastases and invasion of adjacent tissue.